Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
All content for Fenben® Voices is the property of Fenbendazole Help and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
S1EP3 Unveiling Fenbendazole: From Animal Dewormer to Cancer-Fighting Hope
Fenben® Voices
6 minutes
2 years ago
S1EP3 Unveiling Fenbendazole: From Animal Dewormer to Cancer-Fighting Hope
Got Questions? Send us a message!Podcast Episode Description:Join us in this enlightening episode of "Fenben Voices" as we explore "Unveiling Fenbendazole: From Animal Dewormer to Cancer-Fighting Hope." Dive deep into the transformation of Fenbendazole, a medication once solely recognized for treating animal parasites, now emerging as a beacon of hope in cancer research. In this episode, we discuss:Fenbendazole's Traditional Role: Its longstanding use in veterinary medicine as a potent deworm...
Fenben® Voices
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
